Beyond Air (XAIR) Share-based Compensation (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 651.50% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 26.58% |
| Mar 31, 2025 | -93.63% |
| Dec 31, 2024 | 726.33% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 101.78% |
| Mar 31, 2024 | -2,501.43% |
| Dec 31, 2023 | -89.16% |
| Sep 30, 2023 | 5.64% |
| Jun 30, 2023 | 147.76% |
| Mar 31, 2023 | -2,234.00% |
| Dec 31, 2022 | -14.29% |
| Sep 30, 2022 | 0.86% |
| Jun 30, 2022 | -79.25% |
| Mar 31, 2022 | 259.57% |
| Dec 31, 2021 | -19.48% |
| Sep 30, 2021 | -5.02% |
| Jun 30, 2021 | 44.93% |
| Mar 31, 2021 | -20.92% |
| Dec 31, 2020 | -10.08% |
| Sep 30, 2020 | -35.01% |
| Jun 30, 2020 | 77.82% |
| Mar 31, 2020 | 42.89% |
| Dec 31, 2019 | -22.58% |
| Sep 30, 2019 | -1.97% |
| Jun 30, 2019 | 9.94% |
| Mar 31, 2019 | 11.84% |
| Dec 31, 2018 | -9.05% |
| Sep 30, 2018 | 952.51% |
| Jun 30, 2018 | -45.37% |
| Mar 31, 2018 | -34.23% |
| Dec 31, 2017 | -52.12% |
| Sep 30, 2017 | -74.48% |
| Jun 30, 2017 | -2.95% |
| Mar 31, 2017 | 37,648.84% |
| Dec 31, 2016 | -105.88% |
| Sep 30, 2016 | -12.37% |
| Jun 30, 2016 | -48.40% |